qualifying primary and secondary packaging materials.

3. Responsibilities

• Formulation Development Team: Initiates packaging material selection and evaluates compatibility.
• QA Department: Ensures regulatory compliance and approves packaging materials.
• Procurement Team: Sources and qualifies approved vendors for packaging materials.

4. Accountability

The Head – Manufacturing and Head – Quality Assurance are accountable for implementation and documentation of packaging material selection activities.

5. Procedure

5.1 Identification of Packaging Needs

1. Based on the physicochemical characteristics of the gel, identify necessary packaging attributes (e.g., light protection, moisture barrier, ease of dispensing).
2. Decide whether the formulation requires tubes, jars, sachets, or pump containers as primary packaging.
3. Consider shelf life, market preference, and regulatory expectations in selection criteria.

5.2 Evaluation of Primary Packaging

1. Shortlist materials such as:
   • Aluminum Laminated Tubes
   • LDPE/HDPE Plastic Tubes
   • Glass or Plastic Jars
2. Conduct compatibility studies using trial fills of gel product in shortlisted packaging.
3. Test for extractables, leachables, interaction with actives, and physical stability (Annexure-1).

5.3 Evaluation of Secondary Packaging

1. Choose cartons, outer boxes, leaflets, and tamper-proof seals.
2. Evaluate for label adhesion, print durability, and storage conditions.

5.4 Compatibility and Stability Testing

1. Perform accelerated and real-time stability studies to confirm integrity of product within the selected packaging.
2. Monitor pH, viscosity, microbial count, appearance, and preservative efficacy.
3. Document results in Packaging Evaluation Report (Annexure-2).

5.5 Regulatory and GMP Considerations

1. Ensure packaging complies with pharmacopeial standards (USP, IP, BP) and relevant regulatory guidelines (e.g., FDA 21 CFR 211).
2. Vendor certification must include DMF, CoA, RoHS, and declaration of absence of harmful substances (Annexure-3).

5.6 Finalization and Documentation

1. Finalize packaging based on stability, compatibility, and commercial feasibility.
2. Update Master Packaging Specifications and upload documents to document control system.

6. Abbreviations

• GMP: Good Manufacturing Practices
• QA: Quality Assurance
• DMF: Drug Master File
• CoA: Certificate of Analysis

7. Documents

1. Packaging Material Compatibility Report – Annexure-1
2. Packaging Evaluation Report – Annexure-2
3. Vendor Compliance Dossier – Annexure-3

8. References

• ICH Q1A(R2) – Stability Testing of New Drug Substances and Products
• 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name
Designation	Jr. Production Chemist	QA Executive	Head – Manufacturing
Department	Gel Manufacturing	Quality Assurance	Manufacturing

11. Annexures

Annexure-1: Packaging Material Compatibility Report

Packaging Type	Observation	Result
Plastic Tube	No migration, stable viscosity	Pass

Annexure-2: Packaging Evaluation Report

Material	Test Parameter	Result
Alu Tube	Integrity, Dispensing	Suitable

Annexure-3: Vendor Compliance Dossier

Vendor	Documents Submitted	Review Status
ABC Packaging Ltd.	DMF, CoA	Approved

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
01/06/2022	1.0	Initial Release	New SOP	QA Head
02/06/2025	2.0	Expanded packaging evaluation details	Periodic Review	QA Head